Theravance Biopharma Inc. (NASDAQ: TBPH) stock fell -0.91% on Wednesday to $10.94 against a previous-day closing price of $11.04. With 0.6 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.57 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $11.00 whereas the lowest price it dropped to was $10.66. The 52-week range on TBPH shows that it touched its highest point at $12.03 and its lowest point at $7.53 during that stretch. It currently has a 1-year price target of $13.40. Beta for the stock currently stands at 0.50.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of TBPH was up-trending over the past week, with a rise of 1.39%, but this was down by -2.23% over a month. Three-month performance surged to 6.73% while six-month performance rose 5.29%. The stock gained 16.38% in the past year, while it has lost -2.50% so far this year. A look at the trailing 12-month EPS for TBPH yields -0.88 with Next year EPS estimates of -0.53. For the next quarter, that number is -0.21. This implies an EPS growth rate of 66.90% for this year and 33.30% for next year.
Float and Shares Shorts:
At present, 62.93 million TBPH shares are outstanding with a float of 50.63 million shares on hand for trading. On Apr 27, 2023, short shares totaled 7.76 million, which was 12.27% higher than short shares on Mar 30, 2023. In addition to Mr. Rick E. Winningham M.B.A. as the firm’s Chairman & CEO, Ms. Rhonda F. Farnum serves as its Chief Bus. Officer and Sr. VP of Commercial & Medical Affairs.
Through their ownership of 99.68% of TBPH’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 72.75% of TBPH, in contrast to 23.46% held by mutual funds. Shares owned by individuals account for 103.55%. As the largest shareholder in TBPH with 16.57% of the stake, The Baupost Group LLC holds 10,419,226 shares worth 10,419,226. A second-largest stockholder of TBPH, Weiss Asset Management LP, holds 7,457,060 shares, controlling over 11.86% of the firm’s shares. Madison Avenue Partners LP is the third largest shareholder in TBPH, holding 7,012,226 shares or 11.16% stake. With a 2.71% stake in TBPH, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 1,701,393 shares are owned by the mutual fund manager. The Vanguard Small Cap Index Fund, which owns about 2.38% of TBPH stock, is the second-largest Mutual Fund holder. It holds 1,493,181 shares valued at 16.17 million. iShares Russell 2000 ETF holds 2.18% of the stake in TBPH, owning 1,370,486 shares worth 14.84 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Mar 30, 2023, TBPH reported revenue of $11.05M and operating income of -$21.51M. The EBITDA in the recently reported quarter was $9.06M and diluted EPS was -$0.11.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for TBPH since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With TBPH analysts setting a high price target of $20.00 and a low target of $9.00, the average target price over the next 12 months is $14.25. Based on these targets, TBPH could surge 82.82% to reach the target high and fall by -17.73% to reach the target low. Reaching the average price target will result in a growth of 30.26% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded TBPH stock several times over the past three months with 14 Buys and 4 Sells. In these transactions, 710,743 shares were bought while 10,969 shares were sold. The number of buy transactions has increased to 15 while that of sell transactions has risen to 26 over the past year. The total number of shares bought during that period was 730,743 while 10,050,592 shares were sold.